Diagnostic and Interventional Radiology
Interventional Radiology - Original Article
Multiple imaging modality-guided radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma in special locations

Multiple imaging modality-guided radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma in special locations

1.

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China

2.

Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai, China

3.

Shanghai Institute of Medical Imaging, Shanghai, China

Diagn Interv Radiol 2020; 26: 131-139
DOI: 10.5152/dir.2019.18540
Read: 556 Downloads: 166 Published: 07 January 2020

PURPOSE

We aimed to evaluate the safety and effectiveness of radiofrequency ablation (RFA) combined with transarterial chemoembolization (TACE) guided by multiple imaging modalities for hepatocellular carcinomas (HCCs) in special (i.e., high-risk or unfavorable) locations compared with those in conventional locations.

 

METHODS

A total of 122 HCC patients were enrolled, including 85 patients (69.7%) with HCC in conventional locations and 37 (30.3%) with HCC in special locations. The clinical data, overall survival (OS), progression-free survival (PFS), and procedure-related adverse events were analyzed.

 

RESULTS

RFA combined with TACE was successfully performed in all patients. Three complications (2.5%) occurred, with no significant difference between the conventional (n=1, 1.2%) and special (n=2, 5.4%) locations (P = 0.218). Complete tumor necrosis rate was not significantly different between the conventional (n=73, 85.9%) and special (n=34, 91.9%) locations at one-month imaging (P = 0.353). After a follow-up of 3–48 months, the PFS was 17 months for patients with HCC in conventional locations and 14 months for patients with HCC in special locations; one-year PFS rate was 68.1% in the conventional location group, not significantly (P = 0.741) different from 59.1% in the special location group. The OS was 28 months in the conventional location group while 32 months in the special location group. The cumulative one- and two-year OS rates were 89.9% and 63.3%, respectively, in the conventional location group, not significantly different from 96.3% and 65% in the special location group (P = 0.273). Age (P = 0.043) and tumor size (P < 0.001) were significant prognostic factors for OS, and tumor size (P < 0.001) was the only significant prognostic factor for PFS.

 

CONCLUSION

RFA guided by multiple imaging modalities combined with TACE may be safe and effective for treating HCCs in special locations.

 

You may cite this article as: Yang BS, Liu LX, Yuan M, et al. Multiple imaging modality-guided radiofrequency ablation combined with transarterial chemoembolization for hepatocellular carcinoma in special locations. Diagn Interv Radiol 2020; 26:131–139.

Files
EISSN 1305-3612